Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillNo recent work listed

Zibo Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1063-0298; OpenAlex author ID A5100675106. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 3

  1. Development of [18F]AlF-NOTA-NT as PET Agents of Neurotensin Receptor-1 Positive Pancreatic Cancer. Last author DOI 10.1021/acs.molpharmaceut.8b00192↗
  2. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00726-017-2430-5↗
  3. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. Last author DOI 10.2967/jnumed.115.155812↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hui Wang · 3 shared papers, 2015–2018 · strength 0.20
  2. Mengzhe Wang · 2 shared papers, 2017–2018 · strength 0.15
  3. Xiaoqin Yin · 1 shared paper, 2017 · strength 0.07
  4. Dan Li · 1 shared paper, 2015 · strength 0.05
  5. Valery G. Krasnoperov · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.